AI assistant
Sending…
Lite Strategy, Inc. — Director's Dealing 2025
Jul 18, 2025
34267_dirs_2025-07-17_c8155f2d-de34-4bc2-bc75-9c3e75a174b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2025-07-15
Reporting Person: Flynn James P (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-07-15 | Stock Option (Right to Buy) | $3.07 | A | 20000 | Acquired | 2035-07-15 | Common Stock (20000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7900 | Direct |
Footnotes
F1: Customary annual grant to non-employee directors of options to purchase shares of common stock was not made during the fiscal year ended June 30, 2025.
More from Lite Strategy, Inc.
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
Feb 17
Interim / Quarterly Report
2026
Feb 17
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 12
Director's Dealing
2026
Feb 12
Annual Report
2025
Dec 30
Proxy Solicitation & Information Statement
2025
Dec 30
Proxy Solicitation & Information Statement
2025
Dec 30
Board/Management Information
2025
Dec 30